Dyrupeg
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Dyrupeg, covering 2023-12-14 to 2026-07-14. Get the full timeline:
Most recent: EMA Authorised: Dyrupeg (pegfilgrastim) — CuraTeQ Biologics (Malta) Limited